Interdigital tinea pedis in immunocompetent patients.
Contraind./Precautions⬆⬇
Contraindicated in:
Hypersensitivity to sertaconazole or other imidazoles.
Use Cautiously in:
OB: Safety not established in pregnancy
Lactation: Safety not established in breastfeeding
Pedi: Children <12 yr (safety and effectiveness not established).
Adv. Reactions/Side Effects⬆⬇
Derm: application site reactions, burning, contact dermatitis, dry skin, tenderness.
Interactions⬆⬇
Drug-Drug:
None reported.
Availability⬆⬇
Cream: 2%;
Route/Dosage⬆⬇
Topical (Adults and Children >12 yr): Apply twice daily for 4 wk.
US Brand Names⬆⬇
Ertaczo
Action⬆⬇
Inhibits synthesis of ergosterol, a component of fungal cell membrane, resulting in cytoplasmic leakage and fungal cell death.
Therapeutic Effects:
Resolution of fungal infection.
Spectrum:
Active against Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum.
Classifications⬆⬇
Therapeutic Classification: antifungals
Pharmacologic Classification: imidazoles
Pharmacokinetics⬆⬇
Absorption: Minimal systemic absorption.
Distribution: Unknown.
Metabolism/Excretion: Unknown.
Half-life: Unknown.
Time/Action Profile⬆⬇
ROUTE
ONSET
PEAK
DURATION
top
within 2 wk
unknown
unknown
Patient/Family Teaching⬆⬇
Instruct patient to apply medication as directed for full course of therapy, even if symptoms have improved. Emphasize the importance of avoiding the eyes, nose, mouth, and other mucous membranes. Do not use for disorders other than the one for which it was prescribed.
Patients with athlete’s foot should be taught to wear well-fitting, ventilated shoes and to change shoes and socks at least once a day.
Advise patient to report increased skin irritation, redness, itching, burning, blistering, swelling, oozing, or lack of response to therapy to health care professional.
Advise females of reproductive potential to notify health care professional if pregnancy is planned or suspected or if breastfeeding.